Koyfin Home > Directory > Health Care > Adamas Pharma > Price / Earnings (ltm)

Adamas Pharma Price / Earnings (ltm) Chart (ADMS)

Adamas Pharma annual/quarterly Price / Earnings (ltm) from 2014 to 2015. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Adamas Pharma Price / Earnings (ltm) for the quarter ending August 08, 2015 was 139.16 a -3.27% decrease of -4.55 year over year
  • Adamas Pharma Price / Earnings (ltm) for the last 12 months ending August 08, 2015 was 139.16 a -3.27% decrease of -4.55 year over year
  • Adamas Pharma Annual Price / Earnings (ltm) for 2015 was 139.16 a 0.25% increase of 0.35 from 2014
  • Adamas Pharma Annual Price / Earnings (ltm) for 2015 was 138.81 a -0.34% decrease of -0.47 from 2014
  • Adamas Pharma Annual Price / Earnings (ltm) for 2015 was 139.27 a -3.19% decrease of -4.44 from 2014
Other Valuation Metrics:
  • Adamas Pharma Market Cap for the quarter ending March 03, 2018 was $641m a 38.96% increase of 250m year over year
  • Adamas Pharma Price / Book for the quarter ending March 03, 2018 was 8.43 a 61.32% increase of 5.17 year over year
  • Adamas Pharma Enterprise Value for the quarter ending March 03, 2018 was $570m a 51.05% increase of 291m year over year
View Chart On Koyfin

Quarterly ADMS Price / Earnings (ltm) Data

08/2015139.16
08/2015138.81
08/2015139.27
08/2015143.71
08/2015144.41
08/2015144.47
07/2015144.59
07/2015145.58
07/2015148.15
07/2015154.98

Annual ADMS Price / Earnings (ltm) Data

2015139.16
2015138.81
2015139.27
2015143.71
2015144.41
2015144.47
2015144.59
2015145.58
2015148.15
2015154.98